| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥119.4B | ¥51.3B | +132.7% |
| Operating Income | ¥23.4B | ¥13.3B | +76.4% |
| Profit Before Tax | ¥21.1B | ¥12.2B | +73.5% |
| Net Income | ¥15.1B | ¥8.7B | +73.8% |
| ROE | 22.2% | 14.3% | - |
FY2025 consolidated results showed substantial expansion driven by M&A activity. Revenue reached ¥119.4B (YoY +132.7%), Operating Income ¥23.4B (+76.4%), Ordinary Income ¥5.1B (+2.6%), and Net Income ¥15.1B (+73.8%). The revenue surge reflects consolidation of 6 newly acquired subsidiaries during the period, with operating margin maintained at 19.6% demonstrating operational efficiency amid rapid expansion. Basic EPS expanded to ¥118.59 from ¥72.11 (+64.5%). However, the substantial gap between Operating Income (¥23.4B) and Ordinary Income (¥5.1B) warrants attention, indicating ¥18.3B of net non-operating expenses predominantly from financial costs and other expenses. Total assets increased to ¥267.4B with equity at ¥67.7B, resulting in equity ratio of 28.2%, reflecting elevated leverage from debt-financed acquisitions. Goodwill stands at ¥116.5B, exceeding total equity by 72%, representing the most significant balance sheet concentration risk.
Revenue growth of +132.7% was primarily driven by consolidation of 6 new subsidiaries during the period, reflecting an aggressive M&A-led expansion strategy rather than organic growth. The company operates a single DX business segment with no segment breakdown disclosed. Gross profit reached ¥71.3B with gross margin of 59.7%, demonstrating strong pricing power and service economics. SG&A expenses increased to ¥52.2B (43.8% of revenue), rising in absolute terms but declining as a percentage of revenue compared to the prior period baseline, indicating operational leverage benefits. Other income of ¥29.8B and other expenses of ¥25.4B contributed net ¥4.4B to operating results, likely reflecting gains from business restructuring or asset transactions related to M&A integration activities.
The profit cascade reveals significant compression below operating income. Operating income of ¥23.4B faced ¥2.5B in finance costs (interest on acquisition debt) and net other expenses, resulting in profit before tax of ¥21.1B. After tax expense of ¥6.1B (effective tax rate 28.9%), net income reached ¥15.1B. The ¥18.3B gap between operating income and ordinary income reflects ¥2.3B net finance costs plus ¥4.4B net other expenses (impairment losses of ¥23.4B recorded in cash flow statement indicate significant non-cash charges). This represents revenue up/profit up pattern, but with substantial non-operating headwinds constraining net margin to 12.6% versus operating margin of 19.6%.
[Profitability] ROE 20.4% reflects elevated financial leverage rather than purely operational excellence, with DuPont components showing net margin 12.6%, asset turnover 0.45x, and financial leverage 3.95x. Operating margin 19.6% demonstrates strong core business economics. [Cash Quality] Cash and equivalents ¥80.6B provide short-term debt coverage of 2.84x against current bonds and borrowings of ¥28.4B, indicating adequate liquidity buffers. Operating CF of ¥13.5B represents 0.89x net income, suggesting reasonable cash conversion though not full alignment. [Investment Efficiency] Asset turnover 0.45x reflects capital-intensive M&A expansion with total assets reaching ¥267.4B. Trade receivables increased to ¥21.3B, implying DSO of approximately 65 days, elevated versus typical 60-day industry standards and warranting collection monitoring. [Financial Health] Equity ratio 28.2% indicates moderate leverage. Current ratio data unavailable from quarterly statements, but debt-to-equity ratio stands at 1.83x (total interest-bearing debt ¥123.9B versus equity ¥67.7B), rising to 2.95x when including other financial liabilities, exceeding prudent thresholds and flagging material leverage risk. Goodwill of ¥116.5B represents 172% of equity, creating substantial impairment vulnerability.
Operating CF of ¥13.5B represents 0.89x net income of ¥15.1B, with the differential explained by non-cash charges including ¥23.4B impairment losses (non-cash) and working capital changes. Trade receivables increased ¥6.6B, consuming cash as credit extended to customers outpaced collections. Operating CF subtotal before working capital was ¥17.3B, reduced by receivables growth but partially offset by ¥1.0B increase in payables. Investing CF of negative ¥36.6B was dominated by subsidiary acquisitions of ¥33.5B plus ¥8.0B for non-controlling interest purchases, with minimal organic CapEx of ¥0.1B, confirming M&A as primary capital allocation focus. Financing CF of ¥41.3B comprised ¥7.3B new bond and borrowing issuance, ¥2.2B short-term borrowing increase, offset by ¥2.1B debt repayments, ¥3.6B share buybacks, and ¥1.3B lease payments. Net cash flow of ¥18.2B increased cash position from ¥62.4B to ¥80.6B. Free cash flow of negative ¥23.1B signals cash consumption phase requiring debt markets access to fund expansion, with sustainability dependent on acquired business integration success and deleveraging timeline.
Ordinary income of ¥5.1B versus operating income of ¥23.4B reveals ¥18.3B net non-operating burden, comprising ¥2.3B net finance costs (¥2.5B costs minus ¥0.2B income) and significant other expenses. The ¥23.4B impairment loss recorded in cash flow statement represents non-recurring write-downs likely related to acquisition fair value adjustments or integration restructuring. Other income of ¥29.8B versus other expenses of ¥25.4B netted ¥4.4B contribution, potentially including business disposal gains or restructuring-related items. Non-operating impacts represent 15.3% of revenue, elevated beyond normal course operations. Operating CF of ¥13.5B approximating net income of ¥15.1B (0.89x ratio) indicates underlying cash generation, though the ¥23.4B non-cash impairment significantly distorts reported earnings versus economic profit. Excluding this extraordinary charge, core earnings quality appears reasonable with cash conversion aligning to reported profits, but the recurring finance cost burden of ¥2.5B (2.1% of revenue) will persist as long as acquisition debt remains outstanding.
Full-year guidance targets revenue ¥145.0B, operating income ¥33.0B, and net income ¥20.0B. Current achievement rates stand at revenue 82.3%, operating income 71.0%, and net income 75.5% of annual targets. These progress rates appear reasonable given typical business seasonality, though Q4 will require strong performance to close remaining gaps, particularly the 29% operating income shortfall. The operating income forecast of ¥33.0B implies ¥9.6B required in remaining periods, suggesting expectation of accelerating profitability. Net income guidance of ¥20.0B versus current ¥15.1B assumes ¥4.9B additional earnings, with forecast assumptions unavailable in disclosed materials. The guidance represents operating income growth of +140.8% YoY and net income growth of +130.9% YoY, continuing the rapid expansion trajectory but requiring successful integration of acquired subsidiaries and realization of projected synergies.
Goodwill impairment risk represents the most material exposure, with ¥116.5B goodwill exceeding total equity of ¥67.7B by 72%. Any impairment recognition would directly reduce equity capital and potentially breach debt covenants. The aggressive M&A strategy of acquiring 6 subsidiaries in one period creates integration execution risk, including potential revenue synergy shortfalls, cost overruns, and cultural integration challenges that could undermine projected returns on invested capital.
Financial leverage risk is elevated with debt-to-equity ratio of 2.95x (including other financial liabilities) and interest-bearing debt of ¥123.9B. Finance costs of ¥2.5B annually consume 10.7% of operating income, creating earnings sensitivity to interest rate movements. The company's ability to service and refinance this debt depends on maintaining strong operating cash generation, vulnerable if acquired businesses underperform.
Working capital pressure from trade receivables growth poses cash flow risk, with receivables reaching ¥21.3B (+72.4% YoY) and DSO extending to 65 days. Further deterioration in collection efficiency would strain operating cash flow already pressured by ¥23.1B negative free cash flow, potentially requiring additional external financing and increasing leverage further.
[Industry Position] (Reference - Proprietary Analysis)
ROE of 20.4% positions favorably relative to typical DX/IT services sector medians in the 8-15% range, though this reflects financial leverage (3.95x) rather than purely operational superiority. Operating margin of 19.6% exceeds typical sector medians of 12-15%, indicating strong service delivery economics and pricing discipline. However, equity ratio of 28.2% falls below sector median range of 40-50%, confirming aggressive balance sheet positioning. Revenue growth of 132.7% vastly exceeds organic sector growth rates of 5-15%, attributable entirely to M&A consolidation effects rather than market share gains. The company's goodwill intensity (172% of equity) substantially exceeds sector norms of 20-40%, highlighting unusual acquisition accounting concentrations. Net profit margin of 12.6% compares reasonably to sector medians of 8-12%, though the extraordinary impairment charges obscure true recurring profitability. These comparisons suggest F CODE is pursuing aggressive market consolidation strategy with strong core margins but elevated financial and integration risks relative to organic-growth peers.
※ Industry: DX/IT Services Sector, Comparison: Market participants, Source: Proprietary analysis
F CODE demonstrates a high-velocity M&A consolidation strategy in the DX services sector, achieving substantial revenue scale through acquisitions of 6 companies in a single period. The core business economics appear sound with operating margins sustained at 19.6% and gross margins of 59.7%, suggesting viable service delivery models beneath the acquisition activity. However, the financial architecture presents material vulnerabilities: goodwill of ¥116.5B exceeding equity by 72% creates asymmetric downside risk if integration disappoints, while debt-to-equity of 2.95x amplifies both returns and risks through leverage. The ¥23.4B impairment charge signals management willingness to recognize missteps promptly, though the magnitude raises questions about acquisition due diligence quality.
Cash flow dynamics reveal a business in investment mode rather than harvesting phase, with negative ¥23.1B free cash flow funded through ¥41.3B financing activities. The ¥2.5B annual finance cost burden (10.7% of operating income) creates ongoing earnings drag until deleveraging occurs. Trade receivables growth outpacing revenue and extending DSO to 65 days suggests potential customer credit quality concerns or aggressive revenue recognition requiring monitoring. The absence of dividend payments with ¥3.6B share buybacks indicates capital allocation prioritizing flexibility over shareholder distributions, appropriate given leverage levels but signaling no near-term income returns for equity holders. Forward guidance implies continued strong growth expectations, dependent on successful realization of acquisition synergies and integration execution that will determine whether current valuation multiples prove justified or excessive.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.